ERBB2 and neoplasm: Since parotic SCC is a rare tumor type, it is difficult to conduct prospective clinical studies to compare which of the existing HER2 directed agents is the most effective, but this case example suggests that antibody–chemotherapy conjugates seem to have promising activity.